To elucidate the effect of long-term weight variability on C-reactive protein (CRP) levels. DESIGN: Cross-sectional study of the circulating CRP. SUBJECTS: A total of 637 Japanese men aged 40-49 y in1997. MEASUREMENTS: Serum CRP levels, body mass index in 1997 (current BMI), the slope of weight on age (weight-slope) representing an individual's weight trend of direction and magnitude, and the root mean square error around the slope of weight on age (weight-RMSE) representing the weight fluctuation magnitude, as calculated by a simple linear regression model in which each value of the subject's five actual weights (aged 20, 25, 30 y, five years ago, and current) was a dependent variable and the subject's ages independent variables. RESULTS: After adjustment for age and confounders, including smoking and health status, the odds ratios of elevated CRP (Z0.06 mg/dl) were 1.83 (95% CI: 1.25-2.69), 2.63 (1.69-4.11), and 10.31 (2.17-48.98) for upper normal-weight (BMI: 22-o25 kg/m 2 ), overweight (25-o30), and obese (Z30) persons, respectively, compared with lower normal-weight persons (18.5-o22). Adjusting for age, confounders, and current BMI, weight-slope was positively associated with CRP level especially among subjects with BMIZ25 kg/m 2 (trend Po0.01), and weight-RMSE was positively associated with CRP level particularly among subjects with BMI o25 kg/m 2 (trend Po0.05). CONCLUSION: Our results suggest a state of low-grade systemic inflammation not only in overweight and obese persons, but also in normal-weight persons with large weight fluctuation, possibly explaining in part the positive association between weight fluctuation and CVD.
Introduction
Obesity and weight gain is widespread in many developed countries. Recently, not only overweight and obese individuals, but also persons of normal weight are trying to lose weight regardless of age or gender. However, weight loss by dietary methods is often temporary, and repeated attempts at weight reduction can result in weight cycling. 1 Intentionally or unintentionally, such variability in body weight is a common phenomenon. Therefore, concern has been raised about the possible negative effects of weight change and weight fluctuation. [2] [3] [4] [5] Some studies [2] [3] [4] have reported a positive relation between weight fluctuation and an increase in all-cause mortality, whereas others 5 have not. On the other hand, a relation between weight fluctuation and mortality from cardiovascular disease (CVD) is fairly consistent. [2] [3] [4] The physiologic basis for this effect is uncertain, although it has been suggested that weight fluctuation may accelerate atherogenesis.
C-reactive protein (CRP) is an acute phase reactant, 6 which is a marker for underlying systemic inflammation. With the availability of highly sensitive assay systems, it has been possible to investigate the association between plasma CRP levels below the conventional upper limit of normal (1 mg/dl) and CVD. Several prospective studies have demonstrated that an elevated CRP level is a strong independent predictor of future myocardial infarction, stroke, peripheral atherosclerosis, and vascular death among apparently healthy men and women. [7] [8] [9] [10] [11] [12] In this study, after first examining the distribution of circulating CRP levels among Japanese, we investigated the cross-sectional relation between CRP levels and overall adiposity (body mass index, BMI). Then, we investigated the effects of long-term weight variability on circulating CRP levels.
Subjects and methods

Subjects
A survey was conducted in 1997 among employees of N Corporation, a manufacturing company in Nagoya, Japan. The participants in the 1997 survey consisted of 764 Japanese male workers aged 40-49 y who responded to a self-reported questionnaire including medical history and lifestyle characteristics. They underwent a physical examination including height and weight measurement, and provided a collection of fasting blood samples. For the present study, we have obtained the actual weights at ages 20, 25, 30 y, and that of 5 y ago (in 1992) from the respective health checkup records. Five subjects with a medical history of cancer were excluded from the present study. Finally, the current analysis is restricted to 637 men with complete available data on all of the actual weights at ages 20, 25, 30, and 5 y ago, together with current weight, and the serum CRP concentration of the provided blood sample. As for the characteristics such as current BMI, smoking status, and CRP levels, there was no difference between these 637 men and 127 excluded men.
Informed consent for the use of personal information for analysis was given by the population of this study. The study protocol was approved by the Ethics Committee of Nagoya University Graduate School of Medicine, Nagoya, Japan.
Body mass index and weight variability indices
Weight and height were measured in the morning fasting state to the nearest 0.1 kg and 0.1 cm, respectively, with subjects wearing light clothing and no shoes at all five time points. BMI was calculated as weight in kilograms divided by the square of height in meters and used as the relative weight. According to clinical guidelines, underweight was defined as o18.5, normal range as 18.5-o25.0, overweight as 25.0-o30.0, and obese as Z30.0 kg/m 2 . Since approximately 70% of the subjects meet the criteria of normal weight, the normal category was further divided into two groups in this study: lower-normal (18.5-o22.0) and uppernormal (22.0-o25.0).
Weight variability was divided into two distinct components, trend over time and fluctuation over time, using a simple linear regression model in which each value of the subject's five actual weights (aged 20, 25, 30 y, five years ago, and current) was a dependent variable and the subject's ages at examination independent ones. The slope coefficient of this model was used to represent an individual's weight trend of direction and magnitude (weight-slope), while the root mean square error (RMSE), a standard deviation around this slope, of this model was used to represent the weight fluctuation magnitude (weight-RMSE). The coefficient of variation (CV) of weight is commonly used to describe weight fluctuation, but a person with a slight and steady weight gain over a long period of time can have the same CV as a person with large weight gains and losses with no overall weight gain. As CV and slope are correlated, one cannot discriminate between a nonlinear slope effect and the instability of changes by CV itself. In contrast, RMSE can be a more sensitive measure of instability regardless of the overall trend.
Biochemical analysis
Venous blood samples were drawn from each participant after 12 h or over fasting. The samples were stored at À801C until assay. Serum CRP level was measured by using nephelometry, a sensitive immunoassay based on latex particle agglutination (N-assay LA CRP-S C-type, Nittobo). The assay is sensitive enough to detect 0.06-20.0 mg/dl of CRP. Undetectable CRP values were recorded as 0.05 mg/dl. CV for repeated measurements of CRP was 4.80%.
Statistical analysis
The subjects were divided into two categories based on the CRP concentration, undetectable (r0.05 mg/dl) and elevated (Z0.06 mg/dl). Outcome variable was defined as an elevated CRP level (Z0.06 mg/dl) which was compared with an undetectable CRP. The relation between current BMI and CRP concentration category was examined by multiple logistic regression analysis. We calculated odds ratios (ORs) and 95% confidence intervals (CIs) for BMI as a categorical variable with lower-normal weight (BMI: 18.5-o22.0 kg/m 2 ) as the reference category. Tests for linear trend were performed on continuous variables. Adjustments were made for potential confounders, including age and smoking status (never, former, current) (model 1). A subsequent model included covariates for age, smoking status, and other diseases associated with low-grade inflammation, including stroke, myocardial infarction, diabetes mellitus, and asthma (model 2). The relations between circulating CRP, weightslope, and weight-RMSE were examined in the same way. Using multiple logistic regression, the ORs of CRP elevation by the quartiles of weight-slope and weight-RMSE were The reference groups were defined in principle as the subjects in the lowest quartiles of weightslope and weight-RMSE. Furthermore, to compare the difference and similarity of the effects of weight-slope and weight-RMSE in BMI categories, ORs stratified below and above BMI 25 kg/m 2 were calculated. All tests were conducted using LOGISTIC procedures in SPSS software, version 10.0 for Windows. 13 
Results
The characteristics of the subjects are shown in Table 1 . Concerning BMI distribution, 71.4% of the subjects were classified as normal weight and those with BMI greater than 30 kg/m 2 accounted for only 1.9% in this study population.
This finding is consistent with those in other studies on Japanese. 14 The distribution of CRP levels was highly skewed to lower levels. The minimum value was less than 0.05 mg/ dl, the maximum value was 5.31 mg/dl, with 25th, 50th, and 75th percentile values of less than 0.05, less than 0.05, and 0.09 mg/dl, respectively. A total of 52.9% of the subjects had undetectable CRP levels. The elevated CRP levels of 0.06-0.09, 0.10-0.99, and 1.00 mg/dl or more were present in 24.5, 21.7, and 0.9%, respectively. A total of 47.1% of the subjects had the elevated CRP levels. CRP levels were higher among men aged 45-49 y (geometric mean: 0.077 mg/dl) compared with men aged 40-44 y (geometric mean: 0.070 mg/dl). Smokers (geometric mean: 0.077 mg/dl) had higher CRP concentration than nonsmokers (geometric mean: 0.069 mg/dl). As for CRP levels in relation to disease, CRP levels were higher among men with a history of stroke (geometric mean: 0.135 mg/dl), myocardial infarction (geometric mean: 0.161 mg/dl), diabetes mellitus (geometric mean: 0.099 mg/dl), and asthma (geometric mean: 0.081 mg/dl) compared with men without a history of stroke (geometric mean: 0.074 mg/dl), myocardial infarction (geometric mean: 0.074 mg/dl), diabetes mellitus (geometric mean: 0.073 mg/dl), and asthma (geometric mean: 0.074 mg/dl), respectively. The prevalence and adjusted ORs for elevated CRP by current BMI category are shown in Table 2 . The prevalence of elevated CRP level increased with increasing BMI. Overweight and obese men were 2.71 and 10.58 times more likely to have mildly elevated CRP levels compared with lower normal-weight persons after adjusting for age and smoking (model 1). The test for trend by a comparison of adjacent categories was significant (Po0.001). After adjusting for age, smoking, stroke, myocardial infarction, diabetes mellitus, and asthma (model 2), the association of elevated CRP level with current BMI was unchanged.
Adjusted ORs for elevated CRP levels by quartile of weightslope are presented in Table 3 . In the overall subjects, the ORs for elevated CRP level had a monotonic increase with increasing weight-slope in models 1 and 2. Adjusting for age, smoking status, and other diseases associated with low-grade inflammation (model 2), the ORs for elevated CRP level were . On adjustment for current BMI (model 3), the association of elevated CRP level with weight-slope was abolished among the subjects with BMI o25 kg/m 2 , whereas a significant increasing trend of ORs was still observed among those with BMI Z25 kg/m 2 .When the analyses were repeated after exclusion of smokers and persons with a medical history or under treatment for stroke, myocardial infarction, diabetes mellitus, or asthma, similar results were obtained. Table 4 shows adjusted ORs for elevated CRP levels by quartile of weight-RMSE. In the overall data set, the ORs of men whose weight had changed at the highest quartile of weight-RMSE were 2.16 (1.37-3.39) and 2.05 (1.30-3.24) in models 1 and 2, respectively (P-value for linear trend o0.001), when the lowest quartile group was referenced.
On further adjustment for current BMI (model 3), this OR was attenuated to 1.50 (95% CI: 0.93-2.43), but a significant increasing trend was still found (P-value for linear trend o0.05). When data were dichotomized at BMI 25 kg/m 2 , the ORs of elevated CRP level increased across quartile of weight-RMSE among subjects with BMI o25 kg/m 2 in all models (Pvalue for linear trend o0.01, o0.01, and o0.05 in model 1, 2, and 3, respectively), whereas there was no associations between elevated CRP level and weight-RMSE among those with BMI Z25 kg/m 2 . After exclusion of smokers and persons with a medical history or under treatment of stroke, myocardial infarction, diabetes mellitus, or asthma, the results remained the same. We also defined elevated CRP level as CRP concentration Z0.10 mg/dl and repeated the same analysis. The associations of elevated CRP level with current BMI, weight-slope, and weight-RMSE were much the same.
Discussion
To the best of our knowledge, this is the first populationbased study that reports the effect of long-term weight variability on serum CRP levels. Most studies 15 concerning the effects of longitudinal weight changes used self-reported body weight by questionnaire and were not free from information bias. The advantage of our study is that we used actual measurements of weight variables.
The results of the present study have several implications. First, our study found a positive association between CRP level and current BMI, although 71.4% of the subjects were classified as having normal-weight. Previous studies 7, 12 in middle-aged and elderly persons have reported a higher prevalence of low-grade inflammation in overweight and obese persons compared with normal-weight persons. However, in these generations, the association between the CRP level and BMI may have been confounded by diseases such as 
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K Tamakoshi et al diabetes mellitus and CVD, which were associated with both obesity and elevated CRP concentrations. 16, 17 We carefully controlled for inflammatory disease and other factors known to influence CRP concentrations. 18 Furthermore, we dichotomized the normal-weight group, since the percentage of normal-weight persons is high in this study population. Overweight and obese persons had a higher prevalence of low-grade inflammation compared with lower normalweight persons. Of interest is our observation that the persons in the upper normal-weight category were 1.83 times more likely to have elevated CRP levels, respectively, compared with those in the lower normal-weight category even among those in the normal-weight range. We also found that the ORs of elevated CRP levels increased with increasing weight-slope independent of current BMI. In other words, the ORs of elevated CRP levels decreased with decreasing weight-slope. This independent effect appeared to be greater among men with BMI Z25 kg/ m . This is consistent with other studies, 21 where adverse effects of weight change on health were seen more often among those who were not overweight, than among those who were overweight.
Approximately 25% of circulating IL-6 is estimated to be released by human subcutaneous adipose tissue in vivo, 22 and IL-6 stimulates the production of CRP in the liver. 23 This might explain the observed associations between current BMI and CRP. Some studies 24 have reported that those who gained weight increased their waist-to-hip circumference ratio or abdominal fat mass and those who reduced weight decreased them. In vitro, human abdominal visceral adipose tissue releases more IL-6 compared to subcutaneous adipose tissue, 25 possibly explaining why the weight gain or loss (weight-slope) was independently associated with elevated CRP level after adjustment for current BMI and several confounders. The theory that weight fluctuation may lead to an unfavorable distribution of body fat is controversial. 26, 27 Metabolic factors besides increased body fatness may underlie the association between weight fluctuation and elevated CRP. It is not yet clear how weight fluctuation increases the risk of morbidity and mortality from coronary heart disease. This may be explained in part by the positive association between weight fluctuation and elevated CRP. CRP has been reported to be an independent risk factor for CVD. Recently, it has been proposed that CRP function not only reflects the extent and inflammatory activity of atherosclerotic lesions themselves, or inflammation elsewhere in the body or both, but this acute phase protein is also directly involved in the pathogenesis of atherothrombosis, through several mechan- 29 and binding of plasma lipoprotein. 28 Several limitations of this study deserve mention. First, our study lacked the information on reasons for the weight changes. We were unable to distinguish intentional from unintentional weight loss. Secondly, we compared the circulating CRP level with current BMI and past body weight change. We did not measure CRP levels in the past and thus could not evaluate the effect of weight change on the change in CRP levels. The directionality of associations cannot be conclusively established because the study is cross-sectional. Third, the subjects in this study comprised apparently middle-aged Japanese men, and thus the results may not apply to women or Westerners with a high BMI.
In conclusion, we have shown that a higher BMI is associated with higher CRP concentrations that could not be explained by inflammatory disease or other factors or diseases known to increase CRP concentrations. These data suggest that a state of low-grade systemic inflammation is present in the overweight and obese. The results of this crosssectional study have also shown that long-term weight gain is associated positively with circulating CRP, especially among overweight and obese men, and that longterm weight fluctuation is associated positively with circulating CRP, especially among normal-weight men. Both associations were independent of current BMI and other confounders. Being overweight and obese pose a considerable cardiovascular health risk, while a number of cardiovascular events occur among the normal-weight population. Since CRP has been shown to be one of the most powerful predictors of risk of cardiovascular events, several findings in this study suggest that not only avoiding weight gain, but also maintaining a stable weight even in the normal-weight range from the adolescence may help to prevent CVD.
